Helios Compounding Pharmacy

What Helios Compounding Pharmacy does

Helios Compounding Pharmacy, doing business as Helios Laboratories, is a privately held Canadian compounding pharmacy founded in 2019 and headquartered in Markham, Ontario. The company provides patient care, naturopathic, and prescription compounding services, positioning itself as a trusted partner for custom compounding solutions tailored to individual patient needs. Its public-facing surface is a single corporate website at helioslab.ca, and there are no disclosed app, API, or integration products. The legal entity is referenced as 'Helios Laboratories,' with no parent company, subsidiaries, or institutional investors disclosed in the available source material.

The business model is a service-based B2B/B2C compounding pharmacy revenue model: prescriptions and custom formulations are dispensed to patients, typically on referral from prescribers (physicians, naturopaths, veterinarians), with revenue generated per script/compounded unit. Pricing is not publicly disclosed, and no marketing, distribution, partnership, or GTM channels are documented in the input data. The company holds no publicly listed patents, trademarks, certifications, or awards, and there is no management team information, certifications, or regulatory actions on record in the supplied sources.

Operationally, the company is a micro-enterprise with 1-10 employees, no disclosed funding history, and an active website status that suggests ongoing operations with no indicators of closure, acquisition, or public listing. Data depth is shallow: there are no disclosed named customers, customer segments, geographic markets beyond the Canadian headquarters, or quantitative revenue/ARR figures. Any investment or competitive assessment should treat the entity as a small, privately held specialty pharmacy with limited externally verifiable operating signals.

Name

Helios Compounding Pharmacy

Legal name

Helios Laboratories

Website

https://helioslab.ca

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Helios Compounding Pharmacy (operating as Helios Laboratories) is a privately held Canadian compounding pharmacy founded in 2019 in Markham, Ontario, providing custom prescription compounding, patient care, and naturopathic services to patients and prescribers.

Ownership category

akta.pro rank

Product category

Compounding Pharmacy

NAICS

Pharmacies and Drug Retailers (45611), Pharmacies and Drug Retailers (456110)

SIC

Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

Keywords

• Compounding pharmacy services
• Custom prescription medications
• Naturopathic pharmacy
• Personalized medication compounding
• Patient-specific formulations

Headquarters

HQ city

Markham

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations

Core offering

Helios Compounding Pharmacy (doing business as Helios Laboratories) is a compounding pharmacy that provides patient care, naturopathic, and prescription compounding services. It formulates customized medications in tailored dosages and delivery forms to meet individual patient needs that commercially manufactured drugs cannot address.

Product overview

Helios Compounding Pharmacy, operating as Helios Laboratories, is a compounding pharmacy providing custom compounding solutions for personalized medication needs.

Differentiator

Problem solved

Functional benefit

Products and services

• Prescription Compounding
• Naturopathic Compounding
• Patient Care Compounding Services

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights2 records

Broad incumbents

• Pharmasave: National Canadian pharmacy banner with many independent owners, including locations that offer compounding services. Competes with Helios for retail prescription foot traffic and prescriber relationships across Ontario.
• Shoppers Drug Mart (Loblaw): Canada's largest retail pharmacy chain with growing specialty and clinical services. Represents the dominant incumbent against which independents like Helios differentiate on personalisation and integrative offerings.
• BioScript Solutions: Canadian specialty pharmacy provider offering patient support programs, specialty drug distribution, and clinical services. A larger incumbent competing in the specialty/custom therapy space adjacent to Helios's compounding niche.
• Rexall / PharmaChoice: Canadian pharmacy retail and banner network with prescription dispensing and some compounding capability. Adjacent competitor for prescription volume and patient mindshare in the Ontario market.

Emerging players

• Avicanna: Canadian commercial-stage biopharmaceutical company with cannabinoid-based prescription and naturopathic products. Adjacent emerging player operating at the intersection of pharma, naturopathic, and personalised medicine, with a partly overlapping patient demographic.

Others

• McKesson Canada: Major pharmaceutical distributor serving Canadian pharmacies, including independent compounders. Comparable as an ecosystem participant — Helios relies on distributors like McKesson for API and base supply.

Direct peers

• Pace Pharmacy & Compounding Centre: Specialty compounding pharmacy in the Greater Toronto Area offering customised medications, hormone replacement, and paediatric preparations. Overlaps with Helios geographically (GTA) and on the compounding-plus-clinical-service proposition.
• CustomMed Compounding Pharmacy: Canadian independent compounder offering custom prescription and naturopathic preparations. Closely comparable to Helios on business model (patient-specific compounding), target customer (prescribers and patients seeking personalised therapy), and scale category.
• The Compounding Pharmacy of Toronto: Independent Toronto compounder providing prescription customisation and integrative-medicine support. Direct analogue as a small-footprint Canadian compounder serving practitioners and patients seeking personalised dosing.
• Apothecare Compounding Pharmacy: Canadian independent pharmacy focused on custom compounding and specialty preparations. Comparable niche operator with similar prescriber-driven demand model and emphasis on patient-specific formulations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/hcompounding
• Facebookfacebook.com/HeliosLaboratories
• LinkedInlinkedin.com/company/helioslaboratories

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Helios Compounding Pharmacy